Bumrungrad announces the direction in 2022 - shifting the future of healthcare

01 Mar 2022

Pharmacist Artirat Charukitpipat (center), CEO of Bumrungrad International Hospital leads the management team, doctors and medical professionals to announce our future direction in 2022. Bumrungrad is determined to be the leader of implementation of Smart Healthcare 5.0 to provide holistic medical care to our patients. We always prioritize the international standards of quality and safety. Bumrungrad is devoted to expanding our centers of excellence to develop expertise in the treatment of every complex medical condition. Bumrungrad will focus on two medical advancements: robotic surgery and genetic testing. We have adopted robotic assisted surgery, using the da Vinci surgical system to perform operations on multiple organ systems. We also provide comprehensive genomic and genetic testing to assess risks of developing hereditary conditions as well as to actively prevent them. These are the highlights of the press conference, "Bumrungrad: Shifting the Future of Healthcare" at Bumrungrad International Hospital.

Bumrungrad announces the direction in 2022 - shifting the future of healthcare

Photo (from left)

  1. Assoc. Prof. Dr. Taveesin Tanprayoon, Chief Medical Officer of Bumrungrad International Hospital
  2. Khun Napas Paorohitya, Chief Marketing Officer of Bumrungrad International Hospital
  3. Pharmacist Artirat Charukitpipat, CEO of Bumrungrad International Hospital
  4. Clinical Prof. Dr. Anusak Yiengpruksawan, Director, Bumrungrad Robotic Surgery Center of Bumrungrad International Hospital
  5. Assist. Prof. Dr. Polakrit Teekakirikul, Cardiologist and Medical Geneticist of Bumrungrad International Hospital

ฝากข่าวประชาสัมพันธ์?

ติดต่อเราได้ที่ facebook.com/newswit